Monoclonal Antibody Against Prolactin Receptor: A Randomized Placebo-Controlled Study Evaluating Safety, Tolerability, and Pharmacokinetics of Repeated Subcutaneous Administrations in Postmenopausal Women
Crossref DOI link: https://doi.org/10.1177/1933719118776806
Published Online: 2019-12-31
Published Print: 2019-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nave, Rüdiger
Jodl, Stefan
Hoffmann, Anja
Gashaw, Isabella
Zollmann, Frank
Berse, Matthias
Höchel, Joachim
Krätzschmar, Jörn
Rohde, Beate
Text and Data Mining valid from 2019-04-01
Version of Record valid from 2019-04-01
Article History
First Online: 31 December 2019